Stock Forecast

  Outset Medical, Inc. ( OM) $ 21.81

-0.60 (-2.83 %)

Symbol OM
Price $21.81
Beta 0.000
Volume Avg. $420.87 thousand
Market Cap $1.04 B
52 Week Range $19.47 - $60.33

Outset Medical, Inc. opened the day at $21.81 which is -2.83 % on yesterday's close. Outset Medical, Inc. has a 52 week high of $60.33 and 52 week low of $19.47, which is a difference of $40.86. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $1.04 B and total net profit is $102602000 which means the company is trading at 10.16 times profit to market capitalization. Theoretically, if you were to buy Outset Medical, Inc. for $1.04 B, it would take 15 years to get your money back. Outset Medical, Inc. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


Outset Medical, Inc. Stock Forecast - Is Outset Medical, Inc. a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreSell
ROA ScoreNeutral
DE ScoreNeutral
PE ScoreStrong Sell
PB ScoreStrong Buy
Overall RecommendationNeutral

Growth and Value

PE Ratio -7.462
Dividend Yiel 0.000
Net Profit Margin -1.259

Valuing Outset Medical, Inc.

Price Book Value Ratio 2.998 Price To Book Ratio 2.998
Price To Sales Ratio 9.395 Price Earnings Ratio -7.462

How liquid is Outset Medical, Inc.

Current Ratio 7.720
Quick Ratio 6.733


Debt Ratio 0.200 Debt Equity Ratio 0.250
Long Term Debt To Capitalization 0.095 Total Debt To Capitalization 0.098

Latest news about Outset Medical, Inc.

2 No-Brainer Stocks to Buy Right Now for Less than $55

These companies have low share prices and high potential.

Date : 17/05/2022

Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates

Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -1.52% and 0.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Date : 04/05/2022

Why I'm Over the Moon for This Healthcare Stock -- In One Chart

This company helps keep patients at home with dialysis treatments.

Date : 27/04/2022

Outset Medical to Report First Quarter 2022 Financial Results on Wednesday, May 4, 2022

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2022 after the close of trading on Wednesday, May 4, 2022. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a con

Date : 20/04/2022

2 Medtech Stocks You Can Buy and Hold for the Next Decade

These two companies are leading the charge for improved patient outcomes.

Date : 15/04/2022

About Outset Medical, Inc.

CEO : Ms. Leslie L. Trigg
Sector : Healthcare
Industry : Medical Devices

Website :

Exchange : NASDAQ Global Select

Description :

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

My Newsletter

Sign Up For Updates & Newsletters